| Literature DB >> 25313318 |
Yoshiki Hayashi1, Haruka Takeno1, Takumi Chinen2, Kyohei Muguruma1, Kohei Okuyama3, Akihiro Taguchi1, Kentaro Takayama1, Fumika Yakushiji1, Masahiko Miura4, Takeo Usui2, Yoshio Hayashi1.
Abstract
A new benzophenone-diketopiperazine-type potent antimicrotubule agent was developed by modifying the structure of the clinical candidate plinabulin (1). Although the right-hand imidazole ring with a branched alkyl chain at the 5-position in 1 was critical for the potency of the antimicrotubule activity, we successfully substituted this moiety with a simpler 2-pyridyl structure by converting the left-hand ring from a phenyl to a benzophenone structure without decreasing the potency. The resultant compound 6b (KPU-300) exhibited a potent cytotoxicity, with an IC50 value of 7.0 nM against HT-29 cells, by strongly binding to tubulin (K d = 1.3 μM) and inducing microtubule depolymerization.Entities:
Keywords: Cyclic dipeptide; anticancer; antimicrotubule agent; diketopiperazine
Year: 2014 PMID: 25313318 PMCID: PMC4190642 DOI: 10.1021/ml5001883
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345